HighVista Strategies Revenue and Competitors

Boston, MA USA

Location

#9305

Growjo Ranking

Investments

Industry

Estimated Revenue & Valuation

  • HighVista Strategies's estimated annual revenue is currently $18.2M per year.(i)
  • HighVista Strategies's estimated revenue per employee is $227,000

Employee Data

  • HighVista Strategies has 80 Employees.(i)
  • HighVista Strategies grew their employee count by 48% last year.

HighVista Strategies's People

NameTitleEmail/Phone
1
ControllerReveal Email/Phone
2
Chief Financial OfficerReveal Email/Phone
3
Associate Director OperationsReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Director Client RelationsReveal Email/Phone
6
Managing Partner & Chief Investment Officer Reveal Email/Phone
7
Investment Operations, ManagerReveal Email/Phone
8
Partner, Head Strategic CapitalReveal Email/Phone
9
PrincipalReveal Email/Phone
10
PartnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.7M784%N/AN/A
#2
$1.6M12N/AN/AN/A
#3
$42.7M1719%N/AN/A
#4
$12.7M6227%N/AN/A
#5
$4M259%N/AN/A
#6
$0.8M1614%N/AN/A
#7
$328.9M1035-3%N/AN/A
#8
$360.1M11336%N/AN/A
#9
$3.3M21-12%N/AN/A
#10
$4.4M288%N/AN/A
Add Company

What Is HighVista Strategies?

HighVista was founded in 2004 and has been dedicated to helping clients preserve and grow their assets by applying the principles of endowment investing. We serve the diverse needs of institutions, foundations and endowments, sovereign wealth funds, family offices and individuals by tailoring investment solutions that allow them to achieve attractive returns within their unique tolerances for risk.

keywords:N/A

N/A

Total Funding

80

Number of Employees

$18.2M

Revenue (est)

48%

Employee Growth %

N/A

Valuation

N/A

Accelerator

HighVista Strategies News

2022-04-19 - ProPhase Labs, Inc. (NASDAQ:PRPH) Expected to Post ...

HighVista Strategies LLC purchased a new stake in ProPhase Labs in the third quarter valued at approximately $105,000.

2022-04-17 - Stock Down 98% From Peak, Bluebird Bio Could Run Out Of Cash

Andre Perold, chief investment officer and cofounder of the Boston investment firm HighVista Strategies, told the Globe “It is arguably the...

2022-03-22 - Up and Coming Biotech Innovations Investors Should Know ...

Other investors, like Andre Perold, CIO at HighVista Strategies, agree. “I would say the most promising innovations often involve gene...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.6M80-6%N/A
#2
$8.2M803%N/A
#3
$11.6M8036%$17.1M
#4
$21.6M8057%N/A
#5
$11.2M80-8%$29.4M